Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-140846

Chief Executive Officer acquired 13,751 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2024-12-24 Option exercise +13,751 $16.21 $222,904 195,291 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2024-12-24 Option exercise · Stock Option (Right to Buy) −13,751 0 D
Loading xslF345X05/ownership.xml…